Supercharge Clinical Translation by Advancing Gene Engineering, Optimizing Differentiation & Enhancing Expansion to Achieve Unrivalled Clinical Scale for the Future of Cell Therapy
The iPSC-Derived Cell Therapies Summit is back for its second year and this time it’s bigger, better and being hosted in Boston, MA. Boasting the most comprehensive iPSC program yet, advance your team with two tracks of content, spanning translation and discovery to CMC and regulation. This dedicated meeting is your one-stop shop to see the key advances and learn from the industry’s leaders including Century Therapeutics, Sana Biotechnology and Vita Therapeutics, to solve your differentiation, expansion, quality and engineering challenges.
Unite and reconnect with the community driven to create best-in-class, safe and effective iPSC-derived therapies at the world’s flagship iPSC forum.
The 2nd iPSC-Derived Cell Therapies Summit returns with an updated, expanded and exciting 2022 agenda. Now with two tracks, 28+ industry leading speakers (including 12 new speaking companies) and more networking opportunities, this is your one-stop shop to connect with iPSC trailblazers, including Century Therapeutics, Sana Biotechnology and Novo Nordisk, to create best-in-class iPSC-derived cell therapies for immuno-oncology and regenerative medicine.
Download the event guide here to:
- Discover 28+ expert speakers, including 12 speaking companies that are new this year
- Explore two comprehensive tracks of content across discovery, translation, CMC and regulation
- Discover who your next collaborators could be to secure the future of off-the-shelf cell therapies
- Review the details of 17 presentations, 4 panel discussions, 2 roundtables and multiple face-to-face networking sessions
2021 attending companies included:
